KATIE ZILIAK: Open Payments
NPI 1558747097 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,920 in 48 payments from 13 companies in 2025. Trend: 2023 $1,595 · 2024 $1,726 · 2025 $1,920
Food & beverage: $1,920
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $600 |
| PFIZER INC. | 13 | $351 |
| Alexion Pharmaceuticals, Inc. | 9 | $222 |
| Inspire Medical Systems, Inc. | 1 | $180 |
| Aimmune Therapeutics, Inc. | 5 | $127 |
| ABBVIE INC. | 3 | $93 |
| Ferring Pharmaceuticals Inc. | 3 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $77 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
Products named: Rapiblyk, VYNDAQEL, ULTOMIRIS, INSPIRE, VOWST, DALVANCE, REBYOTA, XIFAXAN.
Industry payments across TX — which companies pay providers there.
